Elixir Medical Announces Significant Late Breaking Clinical Results for DynamX Bioadaptor Demonstrating Nearly 50% Reduction in Coronary Event Rates vs. Current PCI Standard of Care
Results were presented at the Transcatheter Cardiovascular Therapeutics (TCT) Conference 2025 in…
